Literature DB >> 26686082

Drug delivery to macrophages: Challenges and opportunities.

Yihua Pei1, Yoon Yeo2.   

Abstract

Macrophages are prevalent in the body and have roles in almost every aspect of human biology. They have often been considered a subject to avoid during drug delivery. However, with recent understanding of their diverse functions in diseases, macrophages have gained increasing interest as important therapeutic targets. To develop drug carriers to macrophages, it is important to understand their biological roles and requirements for efficient targeting. This review provides an overview of representative carriers and various approaches to address challenges in drug delivery to macrophages such as biodistribution, cellular uptake, intracellular trafficking, and drug release.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intracellular drug delivery; Intracellular infection; Macrophages; Targeted delivery; Tumor-associated macrophages

Mesh:

Substances:

Year:  2015        PMID: 26686082     DOI: 10.1016/j.jconrel.2015.12.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

Review 1.  Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells.

Authors:  Xiaoyu Li; Charos Omonova Tuychi Qizi; Amari Mohamed Khamis; Can Zhang; Zhigui Su
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.200

2.  Antimycobacterial compound of chitosan and ethambutol: ultrastructural biological evaluation in vitro against Mycobacterium tuberculosis.

Authors:  M E F A G Oliveira; Y J A Silva; L A Azevedo; L A Linhares; L M L Montenegro; S Alves; R V S Amorim
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-29       Impact factor: 4.813

Review 3.  Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.

Authors:  Maggie Musick; Xianzhong Yu
Journal:  Immunol Res       Date:  2022-04-29       Impact factor: 4.505

Review 4.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

5.  In Vivo Editing of Macrophages through Systemic Delivery of CRISPR-Cas9-Ribonucleoprotein-Nanoparticle Nanoassemblies.

Authors:  Yi-Wei Lee; Rubul Mout; David C Luther; Yuanchang Liu; Laura Castellanos-García; Amy S Burnside; Moumita Ray; Gulen Yeşilbag Tonga; Joseph Hardie; Harini Nagaraj; Riddha Das; Erin L Phillips; Tristan Tay; Richard W Vachet; Vincent M Rotello
Journal:  Adv Ther (Weinh)       Date:  2019-08-15

6.  Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.

Authors:  Mengmeng Niu; Solange Valdes; Youssef W Naguib; Stephen D Hursting; Zhengrong Cui
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

7.  Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.

Authors:  Liang Pang; Ying Zhu; Jing Qin; Wenjie Zhao; Jianxin Wang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

8.  Effects of Compositional Tailoring on Drug Delivery Behaviours of Silica Xerogel/Polymer Core-shell Composite Nanoparticles.

Authors:  Wenfei Huang; Chi Pong Tsui; Chak Yin Tang; Linxia Gu
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

Review 9.  Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.

Authors:  Qin Wang; Xianyan Qin; Jiyu Fang; Xun Sun
Journal:  Acta Pharm Sin B       Date:  2021-03-12       Impact factor: 11.413

Review 10.  Administration of signalling molecules dictates stem cell homing for in situ regeneration.

Authors:  Xuan Li; Xiao-Tao He; Yuan Yin; Rui-Xin Wu; Bei-Min Tian; Fa-Ming Chen
Journal:  J Cell Mol Med       Date:  2017-08-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.